Treatment of high potassium with Kayexalate powder in hemodialysis patients
https://libcat.nshealth.ca/en/permalink/chpams35337
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2021.
- Pamphlet Number
- 1445
- Available Online
- View Pamphlet
People with kidney disease have a higher chance of having high potassium levels. High potassium levels may lead to an irregular heartbeat or cause problems with muscles and nerves. Kayexalate® is a drug that treats high potassium levels. This pamphlet explains how to take Kayexlate®, side effects, and how to store this medication.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2021
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal Dialysis
- Polystyrene sulfonic acid
- Hyperkalemia
- Subjects (LCSH)
- Drugs
- Low-potassium diet
- Specialty
- Nephrology
- Medications
- Abstract
- People with kidney disease have a higher chance of having high potassium levels. High potassium levels may lead to an irregular heartbeat or cause problems with muscles and nerves. Kayexalate® is a drug that treats high potassium levels. This pamphlet explains how to take Kayexlate®, side effects, and how to store this medication.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1445
